NCT00540683

Brief Summary

The researcher can use Diffuse Optical spectroscopy technique that uses harmless levels of near-infrared light to probe the concentrations and states of important physiological molecules such as hemoglobin water and lipids in human muscle,.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2004

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2004

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

October 4, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 8, 2007

Completed
10.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
Last Updated

October 20, 2022

Status Verified

October 1, 2022

Enrollment Period

13.8 years

First QC Date

October 4, 2007

Last Update Submit

October 19, 2022

Conditions

Muscle Disorder

Outcome Measures

Primary Outcomes (1)

  • Healthy Muscle

    upto 4 weeks

Interventions

Diffuse Optical SpectroscopyDEVICE

Muscle properties

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study population will be selected from outpatient clinic at University Of California Irvine, and staffs and students.

You may qualify if:

  • Male or Female age 18 years and older
  • Diagnosed of Cachexic condition
  • Diagnosed of Cellulite adult female 18 years and older

You may not qualify if:

  • Pregnant women
  • Taking light sensitive drugs for use in photodynamic therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beckman Laser Institute University of California Irvine

Irvine, California, 92612, United States

Location

MeSH Terms

Conditions

Muscular Diseases

Condition Hierarchy (Ancestors)

Musculoskeletal DiseasesNeuromuscular DiseasesNervous System Diseases

Study Officials

  • Bruce Tromberg, Ph.D

    Beckman Laser Institute University of California Irvine

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Bruce Tromberg,Ph.D.,Director, Beckman Laser Institute and Medical Clinic and Professor, Departments of Biomedical Engineering and Surgery

Study Record Dates

First Submitted

October 4, 2007

First Posted

October 8, 2007

Study Start

October 1, 2004

Primary Completion

July 1, 2018

Study Completion

July 1, 2018

Last Updated

October 20, 2022

Record last verified: 2022-10

Locations

US(1)